MAM
HPTX

Martingale Asset Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Martingale Asset Management’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-15,709
Closed -$378K – 943
2014
Q4 		$378K Buy
15,709
+7,400
+89% +$167K 0.01% 744
2014
Q3 		$210K Buy
+8,309
New +$206K 0.01% 817

Other funds holding HPTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Martingale Asset Management's HPTX Position: Q1 2015 in Review

Martingale Asset Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q1 2015, closing a stake of 15,709 shares — an estimated $378K sold.

Martingale Asset Management first reported a position in HPTX in Q3 2014 and held it in 2 quarters. The position peaked at $378K in Q4 2014. 134 funds tracked by Wall St. Rank hold HPTX as of Q1 2015.

  • Martingale Asset Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Martingale Asset Management sold 15,709 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q1 2015, an estimated $378K.
  • Martingale Asset Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2014 and held it in 2 quarters.
  • Martingale Asset Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $378K in Q4 2014.
  • 134 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q1 2015.

Based on Martingale Asset Management's 13F filing for Q1 2015, filed 12 May 2015.